Sodium, Arterial Stiffness, and Cardiovascular Mortality in Hypertensive Rats

American Journal of Hypertension

Volumn 20, Issue 3, 2007, Pages 319-325

  Mercier, Nathalie ^a,c   Labat, Carlos ^a,c   Louis, Huguette ^a,c   Cattan, Valerie ^a,c   Benetos, Athanase ^a,c   Safar, Michel E ^b,d   Lacolley, Patrick ^a,c  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Arterial stiffness; AT1 antagonist; mortality; salt; SHR model

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; PLACEBO; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY COMPLIANCE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; HEMODYNAMICS; HIGH SODIUM INTAKE; HYPERTENSION; LONGEVITY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; COMPLIANCE; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; RATS; RATS, INBRED SHR; SODIUM CHLORIDE, DIETARY; TETRAZOLES; TIME FACTORS; VALINE;

EID: 33847094582     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.09.002     Document Type: Article

References (29)

1. Stamler J: The INTERSALT study: background, methods, findings, and implications. Am J Clin Nutr 65 2 Suppl (1997) 626S-642S
2. Simon G. Experimental evidence for blood pressure-independent vascular effects of high sodium diet. Am J Hypertens 16 (2003) 1074-1708
3. Simpson F.O. Blood pressure and sodium intake. In: Bulpitt C.J. (Ed). Handbook of Hypertension: Epidemiology of Hypertension (2000), Elsevier, Amsterdam-Lausanne-New York-Oxford-Shannon-Singapore-Tokyo 274-295
4. Tobian L: Salt and hypertension lessons from animal models that relate to human hypertension. Hypertension 17 Suppl I (1991) S152-S158
5. Yamori Y. Environmental influence on the development of hypertensive vascular diseases in SHR and related models, and their relation to human diseases. In: Worcel E., Bonvalet J.P., Langer S.Z., Menard J., and Sassard J. (Eds). New Trends in Arterial Hypertension (1981), Elsevier, Amsterdam 305-320
6. Boegehold M.A., and Kotchen T.A. Relative contributions of dietary Na+ and Cl- to salt-sensitive hypertension. Hypertension 14 (1989) 579-583
7. Hunt R.A., and Tucker D.C. Developmental sensitivity to high dietary sodium chloride in borderline hypertensive rats. Hypertension 22 (1993) 542-550
8. Kaplan N.M., and Lieberman E. Treatment of hypertension drug therapy (1986) 180-272 In: Williams and Wilkins (ed): Clinical Hypertension, 4th ed. Baltimore, London, Los Angeles, Sydney;
9. Bagrov A.Y., and Lakatta E.G. The dietary sodium-blood pressure plot "stiffens.". Hypertension 44 (2004) 22-24
10. Safar M.E., Thuilliez C., Richard V., and Benetos A. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res 46 (2000) 269-276
11. Bardy N., Karillon G.J., Merval R., Samuel J.L., and Tedgui A. Differential effects of pressure and flow on DNA and protein synthesis and on fibronectin expression by arteries in a novel organ culture system. Circ Res 77 (1995) 684-694
12. Labat C., Lacolley P., Lajemi M., de Gasparo M., Safar M.E., and Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 38 (2001) 439-443
13. Bezie Y., Lamazier J.-M.D., Laurent S., Challande P., Cunha R.S., Bonnet J., and Lacolley P. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 18 (1998) 1027-1034
14. Hayoz D., Rutschmann B., Perret F., Niederberger M., Tardy Y., Mooser V., Nussberger J., Waeber B., and Brunner H.R. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 20 (1992) 1-6
15. Langewouters G.L., Wesserling K.H., and Godehard J.A. The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model. J Biomech 17 (1984) 425-435
16. Safar M.E. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens 23 (2005) 673-681
17. Contard F., Sabri A., Glukhova M., Sartore S., Marotte F., Pomies J., Schiavi P., Guez D., Samuel J.L., and Rappaport L. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 22 (1993) 665-676
18. Partovian C., Benetos A., Pommies J.P., and Safar M.E. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol 274 (1998) H1423-H1428
19. Wang D.H., and Du Y. Regulation of vascular type 1 angiotensin II receptor in hypertension and sodium loading: role of angiotensin II. J Hypertens 16 (1998) 467-475
20. Nickenig G., Strehlow K., Roeling J., Zolk O., Knorr A., and Bohm M. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 31 (1998) 1272-1277
21. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol Rev 75 (1995) 519-560
22. Ruiz-Gayo M., Somoza B., Bravo R., Fernandez-Alfonso M.S., and Gonzalez C. Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats. Life Sci 67 (2000) 3153-3162
23. Yokoyama H., Averill D.B., Brosnihan K.B., Smith R.D., Schiffrin E.L., and Ferrario C.M. Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. Am J Hypertens 18 (2005) 922-929
24. Stier Jr. C.T., Chander P., Gutstein N.W.H., Levine S., and Itskovitz H.D. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypertensive effect. Am J Hypertens 4 (1991) 680-687
25. Rocha R., Chander P.N., Zuckerman A., and Stier Jr. C.T. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 33 (1999) 232-237
26. Black H.R. The paradigm has shifted to systolic blood pressure. Hypertension 34 (1999) 386-387
27. Blacher J., Asmar R., Djane S., London G., and Safar M. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33 (1999) 1111-1117
28. Guerin A.P., Blacher J., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103 (2001) 987-992
29. Asmar R.G., London G.M., O'Rourke M.E., Safar M.E., and Reason project coordinators and investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 38 (2001) 922-926